Therapeutics in renal disease: the road ahead for antiproliferative targets.

about

The cell cycle and acute kidney injury.CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury.Recent Progress in the Pathogenesis of Nephrotic Proteinuria

P2860

Q37436067-34EB5370-7472-4141-888A-1563985F7058 Q37575488-F9DBD126-383E-4572-A61D-7C9D70EB8D14 Q57825276-B4E7C55F-CE71-4D00-8D33-12B55827D524

P2860

Therapeutics in renal disease: the road ahead for antiproliferative targets.

Item

http://www.wikidata.org/entity/Q53644742

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Therapeutics in renal disease: the road ahead for antiproliferative targets.

@en

Therapeutics in renal disease: the road ahead for antiproliferative targets.

@nl

type

Item

label

Therapeutics in renal disease: the road ahead for antiproliferative targets.

@en

Therapeutics in renal disease: the road ahead for antiproliferative targets.

@nl

prefLabel

Therapeutics in renal disease: the road ahead for antiproliferative targets.

@en

Therapeutics in renal disease: the road ahead for antiproliferative targets.

@nl

P1476

Therapeutics in renal disease: the road ahead for antiproliferative targets.

@en

P2093

Peter J Nelson

http://www.w3.org/2001/XMLSchema#string

Stuart J Shankland

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of simvastatin on proliferative nephritis and cell-cycle protein expression

Retinoid receptor-specific agonists alleviate experimental glomerulonephritis

Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease

Effects of pentoxifylline, pentifylline and gamma-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts.

The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1.

ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo.

Pharmacokinetics of mycophenolic acid in renal insufficiency.

Development of target-based antineoplastic agents.

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug.

Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.

P304

e6-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000090138

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7430031

http://www.w3.org/2001/XMLSchema#string

P698

16340240

http://www.w3.org/2001/XMLSchema#string

P932

1440889

http://www.w3.org/2001/XMLSchema#string

Therapeutics in renal disease: the road ahead for antiproliferative targets.

about

P2860

P2860

Therapeutics in renal disease: the road ahead for antiproliferative targets.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932